Android Apple

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Shift From Loss To Profit

By Yahoo! Finance   |   6 months ago
Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Shift From Loss To Profit

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company aiming to reach breakeven by 2025, with analysts projecting a profit of US$240m in 2026. The company's growth rate is estimated at 64%, indicating confidence in its future success.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.